Depression Scale (SDS) on the evening before the injection and again one hour after the injection.
RESULTS AND DIscussIoN
Response to methylamphetamine in relation to diagnosis is given in Table I for all patients.
There was a strong tendency for patients to feel per cent of his patients. In our series, only one of the 20 schizophrenic patients showed an aggravation of symptoms, while in 14 there was a brief improvement.
It must be noted again that because of reports that schizophrenic symptoms were aggravated by methylamphetamine 10 
TABu@II
Response to methylamphetamine in depressedwomen aged @oâ€"6ojears someâ€"antidepressant drugs for example necessarily had to be continued over long periods, it was not possible to use Roberts' system of assessment after one and three months.
Patients were assessed on discharge from hospital. There was no significant associa tion between response to methylamphetamine and outcome in any of the diagnostic groups (see Table III ). When the total sample was considered and those patients rated worse after methylamphetamine were compared with the remainder, there was an over-representation of those with a poor outcome in the former group ( x2 = 4 .9 @ p < 0 @@5) At six months after discharge the same comparisons were made, again with negative results; the relationship between poor methylamphetamine response and outcome was no longer demonstrable.
It has been pointed out (Leader, 1970) 
